Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.
Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
RMD Open. 2020 Jun;6(2). doi: 10.1136/rmdopen-2020-001314.
The coronavirus disease 2019 (COVID-19) pandemic has come with many challenges for healthcare providers and patients alike. In addition to the direct burden it has placed on societies and health systems, it had a significant impact in the care of patients with chronic diseases, as healthcare resources were deployed to fight the crisis, and major travel and social restrictions were adopted. In the field of rheumatology, this has required notable efforts from departments and clinicians to adapt to the novel and assure the follow-up of patients with rheumatic and musculoskeletal diseases. In the present viewpoint, we provide a practical approach to tackle this reality. Key measures include setting up preventive team management strategies, optimising communication with patients and reorganising patient care in all its dimensions. We then anticipate the nuances of rheumatology practice as restrictive measures are progressively lifted, while an effective vaccine is still pending. This includes the need to reimpose the same strategy as further waves unfold. Finally, we look ahead and address the lessons we can incorporate into post-COVID-19 rheumatology.
新型冠状病毒病 2019(COVID-19)大流行给医疗保健提供者和患者都带来了许多挑战。除了它给社会和卫生系统带来的直接负担外,它还对慢性病患者的护理产生了重大影响,因为医疗资源被用于应对危机,并且采取了重大的旅行和社会限制措施。在风湿病学领域,这需要部门和临床医生做出显著努力来适应新情况,并确保风湿和肌肉骨骼疾病患者的后续治疗。在本观点中,我们提供了一种实用的方法来应对这一现实。关键措施包括制定预防性团队管理策略,优化与患者的沟通,并重组所有方面的患者护理。然后,我们预计随着限制措施的逐步取消和有效疫苗的推出,风湿病学实践的细微差别。这包括需要在出现进一步浪潮时重新实施相同的策略。最后,我们展望未来,并探讨我们可以将哪些经验教训纳入 COVID-19 后的风湿病学。